MIR1233-2: A Drug Target / Disease Biomarker (G100422845)
MIR1233-2: A Drug Target / Disease Biomarker
MIR1233-2 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in various cellular processes. One of the most well-studied members of this family is MIR1234-2, also known as uncoupling protein 2 (UCP2), which is a protein that is expressed in the brain and has been shown to be involved in a variety of cellular processes, including metabolism, energy homeostasis, and stress resistance.
MIR1233-2 is a protein that is made up of 251 amino acids and has a calculated molecular weight of 31.9 kDa. It is expressed in a variety of tissues, including the brain, heart, and liver, and is also found in various cell types, including neurons, astrocytes, and pericytes. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in various cellular processes.
One of the most well-studied members of this family is MIR1234-2, also known as uncoupling protein 2 (UCP2), which is a protein that is expressed in the brain and has been shown to be involved in a variety of cellular processes, including metabolism, energy homeostasis, and stress resistance. UCP2 is a protein that is involved in the regulation of mitochondrial function and in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to a variety of diseases, including neurodegenerative diseases, cancer, and cardiovascular disease.
MIR1233-2 has been shown to be involved in a variety of cellular processes, including the regulation of mitochondrial function, energy homeostasis, and stress resistance. It is a protein that is expressed in the brain and has been shown to be involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to a variety of diseases, including neurodegenerative diseases, cancer, and cardiovascular disease.
One of the most promising aspects of MIR1233-2 is its potential as a drug target or biomarker. MIR1233-2 has been shown to be involved in a variety of cellular processes that are important for the function and health of cells, and it is thought to be a useful target for the development of new therapeutic strategies for a variety of diseases.
In addition to its potential as a drug target or biomarker, MIR1233-2 is also a useful tool for studying the molecular mechanisms that are involved in the regulation of mitochondrial function and energy homeostasis. This is because it is expressed in the brain and has been shown to be involved in the production of ROS, which can damage cellular components and contribute to a variety of diseases, including neurodegenerative diseases, cancer, and cardiovascular disease. By studying the mechanisms that are involved in the regulation of MIR1233-2, researchers may be able to gain insights into the mechanisms that are involved in the development and progression of these diseases.
Overall, MIR1233-2 is a protein that is expressed in various tissues of the body and is involved in a variety of cellular processes, including the regulation of mitochondrial function and energy homeostasis. Its potential as a drug target or biomarker makes it an attractive target for the development of new therapeutic strategies for a variety of diseases. Further research is needed to fully understand the role of MIR1233-2 in the regulation of cellular processes and its potential as a therapeutic agent.
Protein Name: MicroRNA 1233-2
The "MIR1233-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1233-2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303
